MMP2 and non-small cell lung carcinoma: In non-small cell lung cancer, luteolin inhibited the growth of H460 cells by EGFR/PI3K/AKT pathway and inhibited cell migration by reducing the expression levels of MMP-2 and ICAM-1 (82).